0001708138-20-000116.txt : 20201211
0001708138-20-000116.hdr.sgml : 20201211
20201211160659
ACCESSION NUMBER: 0001708138-20-000116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAGELOS P ROY
CENTRAL INDEX KEY: 0001013064
STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721]
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201383649
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-12-09
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001013064
VAGELOS P ROY
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-12-09
4
A
0
2439
0.0
A
237088
D
Common Stock
2020-10-06
5
G
0
349
0.0
D
143210
I
by CLAT
Common Stock
2020-11-19
5
G
0
2406
0.0
D
47786
I
by Spouse as Trustee
Common Stock
2020-11-19
5
G
0
2406
0.0
A
3609
I
by trust for grandch
Common Stock
2211
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
492.0
2020-12-09
4
A
0
27680
0.0
A
2030-12-09
Common Stock
27680
27680
D
Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**P. Roy Vagelos
2020-12-10